Provexis' lead product is Fruitflow, a bioactive, patented extract from tomatoes that improves the blood flow, which is important in maintaining a healthy heart and cardiovascular system. Fruitflow has already attracted substantial interest from food manufacturers, including Unilever. Provexis also has other products and technologies in development that are of strategic interest to DSM.
Rietveld commented, "We are proud to be shareholder of Provexis. Their ingredients pipeline has valuable health benefits and attractive market potential in line with DSM's ambition levels. Their professional approach in attracting, developing and licensing interesting technologies is key to succeed in this competitive environment."